Brought to you by 
Biofrontera Pharmaceuticals raises €10.8mm with seed round
25 Feb 2003
Executive Summary
Drug discovery and development start-up Biofrontera Pharmaceuticals GMBH (focuses on diseases of the nervous system) raised €10.8mm ($11.6mm) with a seed financing that it says is one of the largest first round financings by a German biotech company.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Biofrontera Pharmaceuticals raises €10.8mm with seed round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice